CJNJ-67652000
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CJNJ-67652000, covering 2026-01-07 to 2026-01-07. Get the full timeline:
Most recent: Clinical Trial Update: CJNJ-67652000 and Prednisone for Treatment of Metastatic Castration-Resistant Prostate Cancer and SPOP Gene Mutations [Phase 2]